SWOT Analysis for RPG Life Sciences Ltd. - Weakness

Add SWOT widget to your site/app

Companies with no Debt

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Undervalued Growth Stocks

Jim Slater's Zulu Principle (Discover Growth Stocks)

Consistent Highest Return Stocks over Five Years

Mid-range Performer (DVM)

Stocks with Consistent Share Price Growth (subscription)

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Strong QoQ EPS Growth in recent results

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

MFs decreased their shareholding last quarter

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks